Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in Am J Geriatr Psychiatry

Retrieve available abstracts of 88 articles:
HTML format



Single Articles


    July 2021
  1. MORTBY ME, Adler L, Aguera-Ortiz L, Bateman DR, et al
    Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials.
    Am J Geriatr Psychiatry. 2021 Jul 1. pii: S1064-7481(21)00380.
    PubMed     Abstract available


  2. TALASLAHTI T, Ginters M, Kautiainen H, Vataja R, et al
    Criminal Behavior in the Four Years Preceding Diagnosis of Neurocognitive Disorder: A Nationwide Register Study in Finland.
    Am J Geriatr Psychiatry. 2021;29:657-665.
    PubMed     Abstract available


    June 2021
  3. RAJKUMAR AP, Hye A, Lange J, Manesh YR, et al
    Next-Generation RNA-Sequencing of Serum Small Extracellular Vesicles Discovers Potential Diagnostic Biomarkers for Dementia With Lewy Bodies.
    Am J Geriatr Psychiatry. 2021;29:573-584.
    PubMed     Abstract available


    May 2021
  4. BURHANULLAH MH, Rosenberg P
    Low-Dose Lithium for Management of Neuropsychiatric Symptoms in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2021 May 21. pii: S1064-7481(21)00324.
    PubMed    


  5. DEVANAND DP, Crocco E, Forester BP, Husain MM, et al
    Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial.
    Am J Geriatr Psychiatry. 2021 May 12. pii: S1064-7481(21)00312.
    PubMed     Abstract available


  6. IRIARTE ES, Jimenez DE
    A Caregiver Must Be Healthy to Be Able to Care.
    Am J Geriatr Psychiatry. 2021;29:473-475.
    PubMed    


  7. ALBERT SM
    Are Medical Care Expenses Higher for Spouses Who Provide Dementia Care?
    Am J Geriatr Psychiatry. 2021;29:476-477.
    PubMed    


  8. TAYLOR WD, Boyd BD, Elson D, Andrews P, et al
    Preliminary Evidence That Cortical Amyloid Burden Predicts Poor Response to Antidepressant Medication Treatment in Cognitively Intact Individuals With Late-Life Depression.
    Am J Geriatr Psychiatry. 2021;29:448-457.
    PubMed     Abstract available


    April 2021
  9. LEE YM, Park JM, Lee BD, Moon E, et al
    The Role of Decreased Cortical Thickness and Volume of Medial Temporal Lobe Structures in Predicting Incident Psychosis in Patients With Alzheimer's Disease: A Prospective Longitudinal MRI Study.
    Am J Geriatr Psychiatry. 2021 Apr 30. pii: S1064-7481(21)00313.
    PubMed     Abstract available


  10. CHAN NK, Gerretsen P, Chakravarty MM, Blumberger DM, et al
    Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy.
    Am J Geriatr Psychiatry. 2021;29:319-332.
    PubMed     Abstract available


    March 2021
  11. GOVEAS JS
    Commentary on "Cannabinoids for Agitation in Alzheimer's Disease".
    Am J Geriatr Psychiatry. 2021 Mar 19. pii: S1064-7481(21)00262.
    PubMed    


    February 2021
  12. CHAN CK, Sieber FE, Blennow K, Inouye SK, et al
    Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients.
    Am J Geriatr Psychiatry. 2021 Feb 4. pii: S1064-7481(21)00166.
    PubMed     Abstract available


  13. KRELL-ROESCH J, Syrjanen JA, Vassilaki M, Lowe VJ, et al
    Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging.
    Am J Geriatr Psychiatry. 2021;29:179-191.
    PubMed     Abstract available


    January 2021
  14. OUTEN JD, Burhanullah MH, Vandrey R, Amjad H, et al
    Cannabinoids for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2021 Jan 27. pii: S1064-7481(21)00030.
    PubMed     Abstract available


  15. KIM D, Wang R, Kiss A, Bronskill SE, et al
    Depression and Increased Risk of Alzheimer's Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors.
    Am J Geriatr Psychiatry. 2021 Jan 6. pii: S1064-7481(20)30600.
    PubMed     Abstract available


  16. ALEXOPOULOS GS
    Neurobiological Targets of Apathy Can Guide Treatment Development.
    Am J Geriatr Psychiatry. 2021;29:63-65.
    PubMed    


    November 2020
  17. GATCHEL JR
    Late-Life Depression and Alzheimer's Disease Pathology: An Ounce of Prevention, a Pound of Cure.
    Am J Geriatr Psychiatry. 2020 Nov 28. pii: S1064-7481(20)30559.
    PubMed    


    September 2020
  18. CHU J, Benjenk I, Chen J
    Incremental Health Care Expenditures of the Spouses of Older Adults With Alzheimer's Diseases and Related Dementias (ADRD).
    Am J Geriatr Psychiatry. 2020 Sep 30. pii: S1064-7481(20)30502.
    PubMed     Abstract available


  19. WEINBERG MS, Patrick RE, Schwab NA, Owoyemi P, et al
    Clinical Trials and Tribulations in the COVID-19 Era.
    Am J Geriatr Psychiatry. 2020;28:913-920.
    PubMed     Abstract available


    August 2020
  20. HAMILTON CA, Matthews FE, Donaghy PC, Taylor JP, et al
    Cognitive Decline in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease: A Prospective Cohort Study.
    Am J Geriatr Psychiatry. 2020 Aug 8. pii: S1064-7481(20)30437.
    PubMed     Abstract available


    July 2020
  21. ORSO B, Mattei C, Arnaldi D, Massa F, et al
    Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia.
    Am J Geriatr Psychiatry. 2020;28:755-763.
    PubMed     Abstract available


    May 2020
  22. LANCTOT KL, Scherer RW, Li A, Vieira D, et al
    Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
    Am J Geriatr Psychiatry. 2020 May 27. pii: S1064-7481(20)30349.
    PubMed     Abstract available


  23. VAN DYCK CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, et al
    Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
    Am J Geriatr Psychiatry. 2020 May 5. pii: S1064-7481(20)30327.
    PubMed     Abstract available


  24. KEMP EC, Ebner MK, Ramanan S, Godek TA, et al
    Statin Use and Risk of Cognitive Decline in the ADNI Cohort.
    Am J Geriatr Psychiatry. 2020;28:507-517.
    PubMed     Abstract available


    April 2020
  25. ISAIA G, Marinello R, Tibaldi V, Tamone C, et al
    Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease.
    Am J Geriatr Psychiatry. 2020 Apr 22. pii: S1064-7481(20)30319.
    PubMed    


  26. BROWN EE, Kumar S, Rajji TK, Pollock BG, et al
    Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2020 Apr 18. pii: S1064-7481(20)30294.
    PubMed     Abstract available


  27. BEAUDREAU SA, Schneider L
    Commentary on "The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum".
    Am J Geriatr Psychiatry. 2020 Apr 15. pii: S1064-7481(20)30291.
    PubMed    


  28. ALMEIDA OP, Ford AH
    Are We Getting Better at Managing Agitation in Dementia?
    Am J Geriatr Psychiatry. 2020;28:401-403.
    PubMed    


    March 2020
  29. CHEN CL, Liang CK, Yin CH, Lin YT, et al
    Corrigendum to 'Effects of Socioeconomic Status on Alzheimer Disease Mortality in Taiwan' [The American Journal of Geriatric Psychiatry 28 (2020) 205-216].
    Am J Geriatr Psychiatry. 2020 Mar 17. pii: S1064-7481(20)30256.
    PubMed    


    February 2020
  30. BANNING LCP, Ramakers IHGB, Kohler S, Bron EE, et al
    The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum.
    Am J Geriatr Psychiatry. 2020 Feb 19. pii: S1064-7481(20)30025.
    PubMed     Abstract available


  31. WEI S, Gao L, Jiang Y, Shang S, et al
    Apolipoprotein E epsilon4 Allele is Associated With Plasma Amyloid Beta and Amyloid Beta Transporter Levels: A Cross-sectional Study in a Rural Area of Xi'an, China.
    Am J Geriatr Psychiatry. 2020;28:194-204.
    PubMed     Abstract available


    January 2020
  32. SWERDLOW NR
    Commentary: Lessons Learned From Animal Models for Schizophrenia.
    Am J Geriatr Psychiatry. 2020;28:20-22.
    PubMed    


  33. TAN ECK, Johnell K, Bell JS, Garcia-Ptacek S, et al
    Do Acetylcholinesterase Inhibitors Prevent or Delay Psychotropic Prescribing in People With Dementia? Analyses of the Swedish Dementia Registry.
    Am J Geriatr Psychiatry. 2020;28:108-117.
    PubMed     Abstract available


  34. BURHANULLAH MH, Tschanz JT, Peters ME, Leoutsakos JM, et al
    Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
    Am J Geriatr Psychiatry. 2020;28:64-71.
    PubMed     Abstract available


    October 2019
  35. FORESTER BP, Rahman AT, Harper DG, Petrides G, et al
    Evolving Evidence for the Efficacy and Safety of ECT for Agitation in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Oct 24. pii: S1064-7481(19)30548.
    PubMed    


  36. GROSSBERG GT, Kohegyi E, Mergel V, Josiassen MK, et al
    Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials.
    Am J Geriatr Psychiatry. 2019 Oct 1. pii: S1064-7481(19)30521.
    PubMed     Abstract available


    August 2019
  37. RANDOLPH C
    The Utility of Episodic Memory Cut-Off Scores for Inclusion in Clinical Trials for Early Symptomatic Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Aug 19. pii: S1064-7481(19)30475.
    PubMed     Abstract available


  38. NOVAK P, Chu J, Ali MM, Chen J, et al
    Racial and Ethnic Disparities in Serious Psychological Distress Among Those With Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2019 Aug 15. pii: S1064-7481(19)30473.
    PubMed     Abstract available


  39. CHAPMAN BP, Phillips C
    Financial Risk Aversion and Incipient Dementia.
    Am J Geriatr Psychiatry. 2019;27:862-864.
    PubMed    


    July 2019
  40. CHANG MC, Lee AY, Kwak S, Kwak SG, et al
    Effect of Resistance Exercise on Depression in Mild Alzheimer Disease Patients With Sarcopenia.
    Am J Geriatr Psychiatry. 2019 Jul 27. pii: S1064-7481(19)30458.
    PubMed    


  41. PRASAD KM
    Digging Deeper Into Delusion Circuitry in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 Jul 3. pii: S1064-7481(19)30425.
    PubMed    


    June 2019
  42. CHEN NC, Liang CK, Yin CH, Lin YT, et al
    Effects of Socioeconomic Status on Alzheimer Disease Mortality in Taiwan.
    Am J Geriatr Psychiatry. 2019 Jun 24. pii: S1064-7481(19)30417.
    PubMed     Abstract available


  43. VYAS CM, Okereke OI
    Vitamin D and Psychosis in Alzheimer Disease: New Insights From Pharmacogenomics Research.
    Am J Geriatr Psychiatry. 2019 Jun 4. pii: S1064-7481(19)30392.
    PubMed    


    May 2019
  44. POLLOCK BG
    Commentary on "When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram".
    Am J Geriatr Psychiatry. 2019 May 27. pii: S1064-7481(19)30387.
    PubMed    


  45. ROSENBERG PB, Outen M S JD, Amjad M D M P H H, Burhanullah M D MH, et al
    Tetrahydrocannabinol Has Potential for Treating Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 May 24. pii: S1064-7481(19)30370.
    PubMed    


  46. PARADISE DM
    Commentary on: Mechanisms Linking White Matter Lesions, Tract Integrity and Depression in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 May 17. pii: S1064-7481(19)30365.
    PubMed    


  47. KRIVINKO JM, Koppel J, Savonenko A, Sweet RA, et al
    Animal Models of Psychosis in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 May 17. pii: S1064-7481(19)30364.
    PubMed     Abstract available


  48. AGA VM
    When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram.
    Am J Geriatr Psychiatry. 2019 May 10. pii: S1064-7481(19)30350.
    PubMed     Abstract available


  49. HERRMANN N, Ruthirakuhan M, Gallagher D, Verhoeff NPLG, et al
    Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 May 8. pii: S1064-7481(19)30355.
    PubMed     Abstract available


    April 2019
  50. YATAWARA C, Lee D, Ng KP, Chander R, et al
    Mechanisms Linking White Matter Lesions, Tract Integrity, and Depression in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Apr 18. pii: S1064-7481(19)30337.
    PubMed     Abstract available


  51. SCHULZ R
    The Future of Caregiver Efficacy Research: Commentary on "Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers".
    Am J Geriatr Psychiatry. 2019 Apr 10. pii: S1064-7481(19)30334.
    PubMed    


  52. QIAN W, Fischer CE, Churchill NW, Kumar S, et al
    Delusions in Alzheimer Disease are Associated With Decreased Default Mode Network Functional Connectivity.
    Am J Geriatr Psychiatry. 2019 Apr 3. pii: S1064-7481(19)30331.
    PubMed     Abstract available


  53. VERMA M
    Reliably Assessing Language Function in Dementia in the 21st Century.
    Am J Geriatr Psychiatry. 2019;27:378-380.
    PubMed    


  54. STARKSTEIN S, Hayhow B
    Apathy in Dementia: Time to StandUp.
    Am J Geriatr Psychiatry. 2019;27:406-407.
    PubMed    


    March 2019
  55. WANG L, Ying J, Fan P, Weamer EA, et al
    Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.
    Am J Geriatr Psychiatry. 2019 Mar 27. pii: S1064-7481(19)30321.
    PubMed     Abstract available


  56. CHENG ST, Chan WC, Lam LCW
    Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers: A Cluster-Randomized Double-Blind Controlled Trial.
    Am J Geriatr Psychiatry. 2019 Mar 26. pii: S1064-7481(19)30305.
    PubMed     Abstract available


  57. PATRICK RE, Hobbs K, Mathias L, Harper DG, et al
    The Limitations of Using Cognitive Cutoff Scores for Enrollment in Alzheimer Trials.
    Am J Geriatr Psychiatry. 2019 Mar 1. pii: S1064-7481(19)30275.
    PubMed    


  58. FUJISHIRO H
    Late-Life Depression and Lewy Body Disease.
    Am J Geriatr Psychiatry. 2019;27:287-289.
    PubMed    


    February 2019
  59. WILSON RS, Yu L, Schneider JA, Bennett DA, et al
    Risk Aversion and Alzheimer Disease in Old Age.
    Am J Geriatr Psychiatry. 2019 Feb 21. pii: S1064-7481(19)30253.
    PubMed     Abstract available


  60. RUTHIRAKUHAN M, Herrmann N, Vieira D, Gallagher D, et al
    The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment.
    Am J Geriatr Psychiatry. 2019 Feb 7. pii: S1064-7481(19)30242.
    PubMed     Abstract available


    January 2019
  61. PRASAD KM
    Delusions in Alzheimer Disease: What Researchers Should Not Forget.
    Am J Geriatr Psychiatry. 2019 Jan 9. pii: S1064-7481(19)30008.
    PubMed    


    December 2018
  62. ZHU CW, Grossman HT, Sano M
    Why Do They Just Sit? Apathy as a Core Symptom of Alzheimer Disease.
    Am J Geriatr Psychiatry. 2018 Dec 17. pii: S1064-7481(18)30599.
    PubMed     Abstract available


    October 2018
  63. YU R, Topiwala A, Jacoby R, Fazel S, et al
    Aggressive Behaviors in Alzheimer Disease and Mild Cognitive Impairment: Systematic Review and Meta-Analysis.
    Am J Geriatr Psychiatry. 2018 Oct 19. pii: S1064-7481(18)30529.
    PubMed     Abstract available


  64. QIAN W, Schweizer TA, Churchill NW, Millikin C, et al
    Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2018 Oct 2. pii: S1064-7481(18)30499.
    PubMed     Abstract available


    September 2018
  65. BOTT NT, Sheckter CC, Yang D, Peters S, et al
    Systems Delivery Innovation for Alzheimer Disease.
    Am J Geriatr Psychiatry. 2018 Sep 28. pii: S1064-7481(18)30494.
    PubMed     Abstract available


  66. LINCOLN KD, Chow TW, Gaines BF
    BrainWorks: A Comparative Effectiveness Trial to Examine Alzheimer's Disease Education for Community-Dwelling African Americans.
    Am J Geriatr Psychiatry. 2018 Sep 21. pii: S1064-7481(18)30487.
    PubMed     Abstract available


    June 2018
  67. DEVANAND DP, Pelton GH, D'Antonio K, Ciarleglio A, et al
    Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial.
    Am J Geriatr Psychiatry. 2018 Jun 28. pii: S1064-7481(18)30333.
    PubMed     Abstract available


    May 2018
  68. GALLAGHER D, Kiss A, Lanctot K, Herrmann N, et al
    Depression and Risk of Alzheimer's Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression.
    Am J Geriatr Psychiatry. 2018 May 9. pii: S1064-7481(18)30327.
    PubMed     Abstract available


  69. MUNRO CE, Donovan NJ, Amariglio RE, Papp KV, et al
    The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia.
    Am J Geriatr Psychiatry. 2018 May 3. pii: S1064-7481(18)30323.
    PubMed     Abstract available


    April 2018
  70. WOODWARD MR, Hafeez MU, Qi Q, Riaz A, et al
    Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging.
    Am J Geriatr Psychiatry. 2018 Apr 19. pii: S1064-7481(18)30247.
    PubMed     Abstract available


    October 2017
  71. CONNORS MH, Ames D, Woodward M, Brodaty H, et al
    Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study.
    Am J Geriatr Psychiatry. 2017 Oct 20. pii: S1064-7481(17)30512.
    PubMed     Abstract available


    September 2017
  72. HUGHES TM, Lockhart SN, Smagula SF
    Blood Pressure's Role in Alzheimer Disease Pathology.
    Am J Geriatr Psychiatry. 2017 Sep 25. pii: S1064-7481(17)30468.
    PubMed    


    July 2017
  73. YOSHIDA K, Roberts R, Suzuki T, Lebowitz B, et al
    Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data.
    Am J Geriatr Psychiatry. 2017;25:708-716.
    PubMed     Abstract available


    June 2017
  74. ERSKINE D, Thomas AJ, Taylor JP, Savage MA, et al
    Neuronal Loss and Alpha-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.
    Am J Geriatr Psychiatry. 2017;25:595-604.
    PubMed     Abstract available


    April 2017
  75. KENNEDY RE, Cutter GR, Wang G, Schneider LS, et al
    Challenging Assumptions About African American Participation in Alzheimer Disease Trials.
    Am J Geriatr Psychiatry. 2017 Apr 25. pii: S1064-7481(17)30306.
    PubMed     Abstract available


    March 2017
  76. GEDA YE, Krell-Roesch J, Sambuchi N, Michel BF, et al
    Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Alzheimer Disease: "Which is the Cart and Which is the Horse?"
    Am J Geriatr Psychiatry. 2017 Mar 16. pii: S1064-7481(17)30256.
    PubMed    


  77. ROSENBERG PB
    New Insights Into Brain Mechanisms Underlying Neuropsychiatric Symptoms in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Mar 8. pii: S1064-7481(17)30243.
    PubMed    


    February 2017
  78. MATIAS-GUIU JA, Cabrera-Martin MN, Valles-Salgado M, Perez-Perez A, et al
    Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints.
    Am J Geriatr Psychiatry. 2017 Feb 3. pii: S1064-7481(17)30194.
    PubMed     Abstract available


    January 2017
  79. WEISSBERGER GH, Melrose RJ, Narvaez TA, Harwood D, et al
    18F-Fluorodeoxyglucose Positron Emission Tomography Cortical Metabolic Activity Associated with Distinct Agitation Behaviors in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 31. pii: S1064-7481(17)30034.
    PubMed     Abstract available


  80. SMITH GS
    Molecular Imaging of the Nicotinic Cholinergic Receptor in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 5. pii: S1064-7481(17)30001.
    PubMed    


  81. SULTZER DL, Melrose RJ, Riskin-Jones H, Narvaez TA, et al
    Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30305.
    PubMed     Abstract available


  82. GATCHEL JR, Donovan NJ, Locascio JJ, Becker JA, et al
    Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30348.
    PubMed     Abstract available


    November 2016
  83. KERNER NA, Roose SP, Pelton GH, Ciarleglio A, et al
    Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study.
    Am J Geriatr Psychiatry. 2016 Nov 17. pii: S1064-7481(16)30303.
    PubMed     Abstract available


  84. REGAN B, Wells Y, Farrow M, O'Halloran P, et al
    MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Nov 16. pii: S1064-7481(16)30302.
    PubMed     Abstract available


    October 2016
  85. LIN A, Brook J, Grill JD, Teng E, et al
    Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Oct 13. pii: S1064-7481(16)30273.
    PubMed     Abstract available


    August 2016
  86. ANTONSDOTTIR IM, Makino KM, Porsteinsson AP
    Dazed and Confused: Medical Cannabis in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Aug 31. pii: S1064-7481(16)30222.
    PubMed    


    July 2016
  87. ROY S, Ficarro S, Duberstein P, Chapman BP, et al
    Executive Function and Personality Predict Instrumental Activities of Daily Living in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Jul 4. pii: S1064-7481(16)30165.
    PubMed     Abstract available


    February 2016
  88. CHOI HJ, Seo EH, Yi D, Sohn BK, et al
    Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Am J Geriatr Psychiatry. 2016;24:144-53.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: